Please assess the completion status of the following clinical trial:

Trial Title: Fecal Microbial Transplantation in Treatment of Irritable Bowel Syndrome; a Double Blinded Placebo Controlled Trial.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria for patients:~* Patients with IBS-D according to Roma 3 criteria~Exclusion Criteria for patients:~* Immunomodulating medication~* Nocturnal abdominal pain~* Constant abdominal pain~* Alarm symptoms like rectal bleeding, weight loss, nightsweats~* Symptomatic heart/vascular/lung disease~* Renal failure~* Known food allergy~* Microscopic/collagenous colitis~* non-compliant~* BMI \<18~Inclusion criteria for donors:~* healthy volunteers~Exclusion criteria for donors~* Tattoos, imprisoning or piercing last 3 months~* Any history of chronic diarrhoea, constipation, inflammatory bowel disease, irritable bowel disease, colorectal polyps or cancer, immunosuppression, morbid obesity, metabolic syndrome, atopica, or fatigue~* positive test for hepatitis B, C, HIV, treponema pallidum~* sexual high risk habits~* antibiotic treatment in the past 3 months

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- Fecal transplantation (Type: EXPERIMENTAL): Fecal transplantation of freshly prepared feces from healthy donor. Application by colonoscope in proximal half of colon.
- Placebo fecal transplantation (Type: PLACEBO_COMPARATOR): Sham transplant subject's own feces. Application by colonoscope in proximal part of colon.

Based on this trial design, predict the completion outcome and termination type (if applicable).